Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

University of Rochester Clinical and Translational Science Institute to Receive $19M from the NIH

University of Rochester President Joel Seligman, right, shakes the hand of Karl Kieburtz, co-director of the University of Rochester Clinical Translational Science Institute.
University of Rochester Medical Center
University of Rochester President Joel Seligman, right, shakes the hand of Karl Kieburtz, co-director of the University of Rochester Clinical Translational Science Institute.

The National Institutes of Health is giving the University of Rochester Medical Center $19 million.

This is the third round of funding for the University of Rochester Clinical and Translational Science Institute, which supports scientific research, health care data analysis and improvements in patient care.

"It’s a very significant award for us. The National Institutes of Health, traditionally has focused on basic research," said Joel Seligman, president and CEO of the University of Rochester.

The NIH funding has allowed them to cover a lot of ground and focus on population health issues, like smoking.

"We have, because of the earlier awards, trained approximately 120 students and researchers to date and significantly developed a network of 18 academic institutions in upstate New York and into Pennsylvania to improve health delivery systems through our region," Seligman said.

 

This third grant puts the total amount of funding from the National Institutes of Health to almost $86 million.

 

"Its placed the university in the vanguard of medical centers who focus on what is called clinical and translational research, which basically means developing new therapies and helping to improve the health of a general population through improved delivery systems," Seligman added.